Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Natural Language Processing to Assess Frequency of Functional Status Documentation for Patients Newly Diagnosed With Colorectal Cancer—Reply

Natural Language Processing to Assess Frequency of Functional Status Documentation for Patients... Letters Corresponding Author: Atul Batra, DM, Department of Medical Oncology, PACS 01 trial, the efficacy of 6 cycles of fluorouracil, epirubicin, Dr. BRA Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, and cyclophosphamide (CEF) is inferior to 3 cycles of CEF fol- New Delhi 10029, India (batraatul85@gmail.com). lowed by 3 cycles of docetaxel (CEF-T). Taken together, 6 cycles Published Online: January 7, 2021. doi:10.1001/jamaoncol.2020.7157 of paclitaxel should be inferior to CEF-T. Therefore, we conclude Conflict of Interest Disclosures: None reported. that superiority of PCb to CEF-T is likely due to the addition of 1. Yu K-D, Ye F-G, He M, et al. Effect of adjuvant paclitaxel and carboplatin on carboplatin. In the neoadjuvant setting, findings of the CALGB survival in women with triple-negative breast cancer: a phase 3 randomized clinical 40603 trial have also suggested that the addition of carbopla- trial. JAMA Oncol. 2020;6(9):1390-1396. doi:10.1001/jamaoncol.2020.2965 tin to neoadjuvant paclitaxel followed by dose-dense AC can 2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): breast cancer. NCCN Evidence Blocks. Version further improve the pCR rate. 6.2020. Accessed November 30, 2020. https://www.nccn.org/professionals/ Finally, in the current trial, the cardiotoxic events were physician_gls/pdf/breast_blocks.pdf relatively rare, and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Natural Language Processing to Assess Frequency of Functional Status Documentation for Patients Newly Diagnosed With Colorectal Cancer—Reply

Loading next page...
 
/lp/american-medical-association/natural-language-processing-to-assess-frequency-of-functional-status-awcG8s20Dj

References (3)

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2020.7621
Publisher site
See Article on Publisher Site

Abstract

Letters Corresponding Author: Atul Batra, DM, Department of Medical Oncology, PACS 01 trial, the efficacy of 6 cycles of fluorouracil, epirubicin, Dr. BRA Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, and cyclophosphamide (CEF) is inferior to 3 cycles of CEF fol- New Delhi 10029, India (batraatul85@gmail.com). lowed by 3 cycles of docetaxel (CEF-T). Taken together, 6 cycles Published Online: January 7, 2021. doi:10.1001/jamaoncol.2020.7157 of paclitaxel should be inferior to CEF-T. Therefore, we conclude Conflict of Interest Disclosures: None reported. that superiority of PCb to CEF-T is likely due to the addition of 1. Yu K-D, Ye F-G, He M, et al. Effect of adjuvant paclitaxel and carboplatin on carboplatin. In the neoadjuvant setting, findings of the CALGB survival in women with triple-negative breast cancer: a phase 3 randomized clinical 40603 trial have also suggested that the addition of carbopla- trial. JAMA Oncol. 2020;6(9):1390-1396. doi:10.1001/jamaoncol.2020.2965 tin to neoadjuvant paclitaxel followed by dose-dense AC can 2. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): breast cancer. NCCN Evidence Blocks. Version further improve the pCR rate. 6.2020. Accessed November 30, 2020. https://www.nccn.org/professionals/ Finally, in the current trial, the cardiotoxic events were physician_gls/pdf/breast_blocks.pdf relatively rare, and

Journal

JAMA OncologyAmerican Medical Association

Published: Mar 21, 2021

There are no references for this article.